Multifocal electroretinogram abnormalities in inflammatory cystoid macular edema.

Multifocal electroretinogram abnormalities in inflammatory cystoid macular edema. - mfERG CME

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON47097

Enrollment

Registered

2017-08-08

Start date

2017-04-03

Completion date

Unknown

Last updated

2024-08-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cystoid macular edema uveitis

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Age *18 years - Inflammatory CME requiring (different) treatment - Mentally competent

Exclusion criteria

Exclusion criteria: - Age

Design outcomes

Primary

Measure	Time frame
To investigate to which extent macular function is affected in patients with inflammatory CME as measured by mfERG. Multifocal ERGs will be analyzed on amplitude, implicit time, and waveform.	—

Secondary

Measure	Time frame
1. To which extent mfERG abnormalities are reversible after treatment. 2. To which extent clinical parameters, including demographics, treatment and ophthalmologic examination results (e.g. OCT value, visual acuity, severity of inflammation scored according to SUN) influence and/or correlate to mfERG abnormalities. 3. To which extend the 30HZ flicker response can be correlated to the mfERG and clinical parameters.	—

Measure

Time frame

1. To which extent mfERG abnormalities are reversible after treatment. 2. To which extent clinical parameters, including demographics, treatment and ophthalmologic examination results (e.g. OCT value, visual acuity, severity of inflammation scored according to SUN) influence and/or correlate to mfERG abnormalities. 3. To which extend the 30HZ flicker response can be correlated to the mfERG and clinical parameters.

—

Countries

Netherlands

Outcome results